DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Schreiber S. et al.
A randomized, placebo-controlled trial of Certolizumab Pegol (CDP870) for treatment of Crohn’s disease.
Gastroenterology 2005; 129: 807-818
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.